Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The International thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: donor and recipient size match.J Heart Lung Transpl. 2019; 38: 1042-1055
- The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics.J Heart Lung Transpl. 2021; 40: 1060-1072
- OPTN/SRTR 2020 annual data report: lung.Am J Transpl. 2022; 22: 438-518
- Effect of the lung allocation score on lung transplantation in the United States.J Heart Lung Transpl. 2016; 35: 433-439
- Geographic disparities in lung transplantation in the United States before and after the November 2017 allocation change.J Heart Lung Transpl. 2022; 41: 382-390
- Effect of broader geographic sharing of donor lungs on lung transplant waitlist outcomes.J Heart Lung Transpl. 2019; 38: 136-144
- How should lungs be allocated for transplant?.Semin Respir Crit Care Med. 2018; 39: 126-137
- Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States.J Cyst Fibros. 2016; 15: 196-203
- Association between allosensitization and waiting list outcomes among adult lung transplant candidates in the United States.Ann Am Thorac Soc. 2019; 16: 846-852
- Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation.J Heart Lung Transpl. 2021; 40: 1349-1379
- Ethical principles in the allocation of human organs.(Available at:)
- Lung transplant referral for individuals with cystic fibrosis: cystic Fibrosis Foundation consensus guidelines.J Cyst Fibros. 2019; 18: 321-333
- Pre-transplant weight loss and clinical outcomes after lung transplantation.J Heart Lung Transpl. 2018; 37: 1443-1447
- Pulmonary rehabilitation in lung transplant candidates.J Heart Lung Transpl. 2013; 32: 626-632
- Physical rehabilitation for lung transplant candidates and recipients: an evidence-informed clinical approach.Worldj Transpl. 2016; 6: 517-531
- Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.Chest. 2010; 137: 129-137
- Clinical significance of histological classification of idiopathic interstitial pneumonia.Eur Respir J. 2002; 19: 275-283
- A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.N Engl J Med. 2014; 370: 2083-2092
- Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria.Am J Respir Crit Care Med. 2017; 195: 78-85
- Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.N Engl J Med. 2014; 370: 2071-2082
- Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis.Lancet Respir Med. 2017; 5: 33-41
- Idiopathic pulmonary fibrosis.N Engl J Med. 2018; 378: 1811-1823
- Lung transplantation for interstitial lung disease.Eur Respir Rev. 2021; 30: 210017
- Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 2011; 184: 459-466
- A multidimensional index and staging system for idiopathic pulmonary fibrosis.Ann Intern Med. 2012; 156: 684-691
- Predictors of mortality in patients with interstitial lung disease-associated pulmonary hypertension.J Clin Med. 2020; 9: 3828
- Predicting outcome in idiopathic pulmonary fibrosis: addition of fibrotic score at thin-section ct of the chest to gender, age, and physiology score improves the prediction model.Radiol Cardiothorac Imaging. 2019; 1: e180029
- Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study).Eur Respir J. 2021; 57
- Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.Am J Respir Crit Care Med. 2007; 175: 705-711
- Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.Eur Respir Rev. 2018; 27: 180076
- Nintedanib in progressive fibrosing interstitial lung diseases.N Engl J Med. 2019; 381: 1718-1727
- Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.Lancet Respir Med. 2020; 8: 147-157
- Nintedanib for systemic sclerosis-associated interstitial lung disease.N Engl J Med. 2019; 380: 2518-2528
- Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.Lancet Respir Med. 2020; 8: 453-460
- Risk factors for disease progression in idiopathic pulmonary fibrosis.Thorax. 2020; 75: 78-80
- Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.Respir Res. 2019; 20: 105
- Connective tissue disease-associated interstitial lung disease and outcomes after hospitalization: a cohort study.Respir Med. 2019; 154: 1-5
- A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.Respirology. 2017; 22: 501-507
- Progression of right ventricular dysfunction and predictors of mortality in patients with idiopathic interstitial pneumonias.J Cardiol. 2020; 75: 242-249
- Influence of pulmonary hypertension on patients with idiopathic pulmonary fibrosis awaiting lung transplantation.Ann Thorac Surg. 2016; 101: 246-252
- Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.Am J Respir Crit Care Med. 2011; 183: 1231-1237
- The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med. 2004; 350: 1005-1012
- Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal.BMJ. 2019; 367: l5358
- Survival of lung transplant candidates with COPD: BODE score reconsidered.Chest. 2018; 153: 697-701
- Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation.Int J Chron Obstruct Pulmon Dis. 2018; 13: 3963-3970
- Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2008; 177: 1156-1163
- Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure.Chest. 1995; 107: 1193-1198
- Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene.Eur Respir J. 2020; 55: 1901812
- Predictors of mortality in patients with emphysema and severe airflow obstruction.Am J Respir Crit Care Med. 2006; 173: 1326-1334
- Longitudinal change in the BODE index predicts mortality in severe emphysema.Am J Respir Crit Care Med. 2008; 178: 491-499
- Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.JAMA. 1995; 274: 1852-1857
- Outcomes and resource utilization among patients admitted to the intensive care unit following acute exacerbation of chronic obstructive pulmonary disease.J Intensive Care Med. 2021; 36: 1091-1097
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.Lancet. 2019; 394: 1940-1948
- Triple therapy for cystic fibrosis phe508del-gating and -residual function genotypes.N Engl J Med. 2021; 385: 815-825
- Rapid improvement after starting elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and advanced pulmonary disease.Am J Respir Crit Care Med. 2021; 204: 64-73
- Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single phe508del allele.N Engl J Med. 2019; 381: 1809-1819
- Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.Lancet Respir Med. 2021; 9: 733-746
- Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV(1).J Cyst Fibros. 2019; 18: 94-101
- Cystic fibrosis foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease.J Cyst Fibros. 2020; 19: 344-354
- Enhancing care for individuals with advanced cystic fibrosis lung disease.Pediatr Pulmonol. 2021; 56: S69-S78
- Prediction of mortality in patients with cystic fibrosis.New Engl J Med. 1992; 326: 1187-1191
- Risk of death in cystic fibrosis patients with severely compromised lung function.Chest. 1998; 113: 1230-1234
- Heterogeneity in survival in adult patients with cystic fibrosis with FEV(1) < 30% of predicted in the United States.Chest. 2017; 151: 1320-1328
- Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation.Ann Thorac Surg. 2015; 100: 474-479
- Effect of including important clinical variables on accuracy of the lung allocation score for cystic fibrosis and chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2019; 200: 1013-1021
- Risk factors for death of patients with cystic fibrosis awaiting lung transplantation.Am J Respir Crit Care Med. 2006; 173: 659-666
- Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.Thorax. 2011; 66: 680-685
- Pulmonary hypertension in cystic fibrosis with advanced lung disease.Am J Respir Crit Care Med. 2014; 190: 898-905
- Pulmonary artery pressure and benefit of lung transplantation in adult cystic fibrosis patients.Ann Thorac Surg. 2016; 101: 1104-1109
- Prognostic value of six minute walk test in cystic fibrosis adults.Respir Med. 2013; 107: 1881-1887
- Outcomes following bronchial artery embolisation for haemoptysis in cystic fibrosis.Cardiovasc Intervent Radiol. 2017; 40: 1164-1168
- Development and internal validation of a prognostic model of 2-year death or lung transplant for cystic fibrosis.Chest. 2022; S0012-3692: 01049-01052
- The bronchiectasis severity index. An international derivation and validation study.Am J Respir Crit Care Med. 2014; 189: 576-585
- 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for European paediatric and congenital Cardiology (AEPC), international society for heart and lung transplantation (ISHLT).Eur Heart J. 2016; 37: 67-119
- Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.Eur Respir J. 2017; 50: 1700740
- Predicting survival in patients with pulmonary arterial hypertension: the reveal risk score calculator 2.0 and comparison with ESC/ERS-Based Risk ASSESSMENT STrategies.Chest. 2019; 156: 323-337
- Impact of declining renal function on outcomes in pulmonary arterial hypertension: a REVEAL registry analysis.J Heart Lung Transpl. 2018; 37: 696-705
- Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.J Am Coll Cardiol. 2011; 58: 2511-2519
- The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension.J Heart Lung Transpl. 2019; 38: 306-314
- Risk stratification and medical therapy of pulmonary arterial hypertension.Eur Respir J. 2019; 53: 1801889
- Pulmonary veno-occlusive disease: recent progress and current challenges.Respir Med. 2010; 104: S23-S32
- Prevalence, treatment, and outcomes of coexistent pulmonary hypertension and interstitial lung disease in systemic sclerosis.Arthritis Rheumatol. 2019; 71: 1339-1349
- Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension.Am J Respir Crit Care Med. 2009; 180: 468-474
- Survival in pulmonary arterial hypertension patients awaiting lung transplantation.J Heart Lung Transpl. 2013; 32: 1179-1186
- Impact of high-priority allocation on lung and heart-lung transplantation for pulmonary hypertension.Ann Thorac Surg. 2017; 104: 404-411
- The lung allocation score and its relevance.Semin Respir Crit Care Med. 2021; 42: 346-356
- Improving survival in patients with pulmonary arterial hypertension: focus on intravenous epoprostenol.Am J Cardiovasc Drugs. 2019; 19: 99-105
- Outcomes and prognostic factors of decompensated pulmonary hypertension in the intensive care unit.Respir Med. 2021; 190: 106685
- Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure.Eur Respir J. 2021; 58: 2100466
- Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.Eur Respir J. 2019; 53: 1801906
- Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.Lancet Respir Med. 2021; 9: 1313-1327
- Efficacy and safety of sirolimus in lymphangioleiomyomatosis.N Engl J Med. 2011; 364: 1595-1606
- Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.Am J Respir Crit Care Med. 2014; 190: 1273-1282
- The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis.Chest. 2019; 155: 288-296
- Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.Lung. 2013; 191: 35-42
- Predictors of mortality in pulmonary sarcoidosis.Chest. 2018; 153: 105-113
- Lung transplantation for pulmonary sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2019; 36: 92-107
- Lung transplantation for sarcoidosis: outcome and prognostic factors.Eur Respir J. 2021; 58: 2003358
- Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.Respir Med. 2009; 103: 1209-1215
- Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis.Respirology. 2019; 24: 55-62
- Acute respiratory distress syndrome: the Berlin Definition.JAMA. 2012; 307: 2526-2533
- Lung transplantation as a therapeutic option in acute respiratory distress syndrome.Transplantation. 2018; 102: 829-837
- Long-term venovenous extracorporeal membrane oxygenation support for acute respiratory distress syndrome.Ann Thorac Surg. 2015; 100: 2059-2063
- Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.N Engl J Med. 2018; 378: 1965-1975
- Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry.Ann Thorac Surg. 1998; 65: 227-234
- Outcomes after lung retransplantation in the modern era.Am J Respir Crit Care Med. 2008; 177: 114-120
- Impact of CLAD phenotype on survival after lung retransplantation: a multicenter study.Am J Transpl. 2015; 15: 2223-2230
- Two decades of lung retransplantation: a single-center experience.Ann Thorac Surg. 2017; 103: 1076-1083
- Outcomes and long-term survival after pulmonary retransplantation: a single-center experience.Ann Thorac Surg. 2019; 108: 1037-1044
- Esophageal disease in lung transplant patients.Ann Transl Med. 2021; 9: 900
- Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.J Thorac Cardiovasc Surg. 2003; 125: 533-542
- Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux.Ann Thorac Surg. 2011; 92 (discussion; 468-469): 462-468
- Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation.Arch Surg. 2011; 146: 1041-1047
- Joint statement about COVID-19 vaccination in organ transplant candidates and recipients.(Available at:)
- Psychosocial issues facing lung transplant candidates, recipients and family caregivers.Thorac Surg Clin. 2012; 22: 517-529
- Depressive symptoms and early mortality following lung transplantation: a pilot study.Clin Transpl. 2017; 31: e12874
- Psychosocial predictors of mortality following lung transplantation.Am J Transpl. 2016; 16: 271-277
- Depression, social support, and clinical outcomes following lung transplantation: a single-center cohort study.Transpl Int. 2018; 31: 495-502
- To transplant or not? The importance of psychosocial and behavioural factors before lung transplantation.Chron Respir Dis. 2006; 3: 39-47
- Lung transplantation for scleroderma lung disease: an international, multicenter, observational cohort study.J Heart Lung Transpl. 2018; 37: 903-911
- Long-term survival in bilateral lung transplantation for scleroderma-related lung disease.Ann Thorac Surg. 2018; 105: 893-900
- Low body mass index as a barrier to lung transplant in cystic fibrosis.J Cyst Fibros. 2022; 21: 475-481
- Underweight patients with cystic fibrosis have acceptable survival following lung transplantation: a united Network for organ sharing registry study.Chest. 2020; 157: 898-906
- Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registry.J Heart Lung Transpl. 2015; 34: 182-188
- Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: a single center experience.Transpl Infect Dis. 2019; 21: e13084
- Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series.Transpl Infect Dis. 2019; 21: e13046
- Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement.Am J Transpl. 2021; 21: 460-474
- Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: a consensus expert opinion statement.Am J Transpl. 2021; 21: 475-483
- An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses.Am J Respir Crit Care Med. 2008; 177: 912-927
- Palliative care in advanced lung diseases: a void that needs filling.Ann Am Thorac Soc. 2018; 15: 1265-1268
- Palliative care for people with COPD: effective but underused.Eur Respir J. 2018; 51: 1702645
- Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: an evolving strategy in the management of rapidly advancing pulmonary disease.J Thorac Cardiovasc Surg. 2015; 149: 291-296
- Twenty-year experience with extracorporeal life support as bridge to lung transplantation.J Thorac Cardiovasc Surg. 2019; 157 (e2510): 2515-2525
- Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center.J Thorac Cardiovasc Surg. 2018; 155: 1316-1328.e1311
- Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation.Am J Respir Crit Care Med. 2012; 185: 763-768
- Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France.J Heart Lung Transpl. 2013; 32: 905-913
- Awake extracorporeal membrane oxygenation as bridge to lung transplantation: a 9-year experience.Ann Thorac Surg. 2017; 104: 412-419
- Extracorporeal membrane oxygenation as a bridge to lung transplantation: what lessons might we learn from volume and expertise?.Interact Cardiovasc Thorac Surg. 2016; 22: 406-410
- Bridging to lung transplantation.Crit Care Clin. 2019; 35: 11-25
- Approaches to the management of sensitized lung transplant candidates: findings from an international survey.J Heart Lung Transpl. 2020; 39: S315
- Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study.Crit Care. 2014; 18: R38
- Commentary: walking wounded: role of ambulatory femoral venovenous extracorporeal membrane oxygenation.JTCVS Tech. 2021; 9: 204-205
- Ambulation with femoral arterial cannulation can Be safely performed on venoarterial extracorporeal membrane oxygenation.Ann Thorac Surg. 2019; 107: 1389-1394
- Urgently listed lung transplant patients have outcomes similar to those of electively listed patients.J Thorac Cardiovasc Surg. 2020; S0022-5223: 30997-31001
- Long-term outcome and bridging success of patients evaluated and bridged to lung transplantation on the ICU.J Heart Lung Transpl. 2022; 41: 589-598
- Lung transplantation for patients with severe COVID-19.Sci Transl Med. 2020; 12: eabe4282
- The effect of the cystic fibrosis care center on outcomes after lung transplantation for cystic fibrosis.J Heart Lung Transpl. 2022; 41: 300-307
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
